RxDoctor Payments Data

Geoffrey Stewart, MD

Orthopaedic Surgery of the Spine · Davenport, FLNPI 1528026812

Payments from drug & device makers

What this record shows

The money is spread across several categories — ownership interests (55.8%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Kalitec Direct LLC accounts for 71.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $176,821 and has fallen 84.8% since, to $26,889 in 2025.

$671,866in general payments, 2019–2025

Across 90 payments — averaging $7465.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kalitec Direct LLC$483K
  • Sanara Medtech Inc.$160K
  • Arteriocyte Medical Systems, Inc.$13K
  • 7d Surgical Inc.$11K
  • Implanet America, Inc.$4K
  • Carlsmed, Inc.$362
  • plus $2K from 15 others
$186,893in ownership & investment interests, 2019–2025

Across 9 payments — averaging $20,766 each. An ownership or investment interest held by the physician or an immediate family member.

  • Kalitec Direct LLC$187K
  • Woven Orthopedic Technologies, LLC$0

What the payments were for

  • Royalty or licence$106,60916%
  • Consulting fees$177,00026%
  • Speaking & faculty fees$2,2500%
  • Travel & lodging$6,7431%
  • Food & beverage$4,2661%
  • Ownership interest$374,99856%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$671,866 in reported general payments places this provider in the 85th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$492,850
Medicare patients
369
Services billed
2,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine33$5,430
Calcitonin-SalmonCalcitonin,salmon,synthetic38$2,982
Gabapentin149$2,000
Methocarbamol110$1,389
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen121$1,202
Pregabalin77$1,178
Celecoxib54$850
Tizanidine Hcl59$640
Meloxicam180$627
Methylprednisolone44$322
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$314
Cyclobenzaprine Hcl15$288
Tramadol Hcl36$245

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Davenport

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →